# Vismodegib on Locally Advanced Basal Cell Carcinoma Under Real World Conditions

> **NCT02781389** · — · COMPLETED · sponsor: **University Hospital, Essen** · enrollment: 53 (actual)

## Conditions studied

- Basal Cell Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02781389
- **Lead sponsor:** University Hospital, Essen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-29
- **Primary completion:** 2021-05-31
- **Final completion:** 2021-05-31
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2021-06-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02781389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02781389, "Vismodegib on Locally Advanced Basal Cell Carcinoma Under Real World Conditions". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02781389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*